00460.HK_Providing professional financial news and data related to 00460.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

SIHUAN PHARM (00460.HK): Xuanzhu Bio's Phase III Anlarazole Data Presented at UEG Week

Tags：

NewTimeSpace SIHUAN PHARM 00460.HK

2026-10-21

SIHUAN PHARM (00460.HK): Two aesthetics products approved in HK

Tags：

SIHUAN PHARM 00460.HK R&D Progress

2026-10-20

SIHUAN PHARM (00460.HK): Dongyan skin booster gets five new specs in China

Tags：

SIHUAN PHARM 00460.HK Drug Production Licence

2026-10-05

SIHUAN PHARM (00460.HK): Five New Specifications of Skin Booster Dongyan Approved for Marketing by NMPA

Tags：

SIHUAN PHARM 00460.HK R&D Progress

2026-10-05

SIHUAN PHARM (00460.HK): Repurchases 10 million shares for about HKD 8.111 million; H1 net profit up 221% year on year

Tags：

SIHUAN PHARM 00460.HK Share Buyback

2026-08-27

SIHUAN PHARM(00460.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 224.7 million, YoY increase of 119%

Tags：

SIHUAN PHARM 00460.HK profit growth

2026-08-26

SIHUAN PHARM (00460.HK): Miao Guili resigns as executive director and CFO, Che Yuxuan appointed non-executive director and Song Xiaomi appointed CFO

Tags：

SIHUAN PHARM 00460.HK resignation

2026-08-26

SIHUAN PHARM(00460.HK): First Patient Dosed in Phase III Trial of Anaprazole Sodium from Xuanzhu Biologics for Helicobacter Pylori Eradication

Tags：

SIHUAN PHARM 00460.HK Clinical Trial

2026-06-22

SIHUAN PHARM (00460.HK): 6 New Specifications of Collagen Stimulating Filler Approved, Improving Regenerative Aesthetic Medicine Product Matrix

Tags：

SIHUAN PHARM 00460.HK

2026-01-16

Scan QR Code

Download App